US Stock MarketDetailed Quotes

SNSE Sensei Biotherapeutics

Watchlist
  • 0.530
  • +0.013+2.51%
Close Jan 8 16:00 ET
  • 0.503
  • -0.027-5.06%
Post 19:28 ET
13.33MMarket Cap-0.45P/E (TTM)

Sensei Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-17.36%-5.47M
38.79%-5.79M
35.11%-7.62M
17.94%-32.02M
35.63%-6.16M
31.49%-4.66M
20.47%-9.46M
-9.17%-11.74M
-28.97%-39.03M
-21.68%-9.57M
Net income from continuing operations
-1.81%-7.25M
23.91%-7.14M
21.47%-7.99M
29.82%-34.1M
39.39%-7.41M
46.90%-7.12M
10.91%-9.39M
17.96%-10.18M
-32.05%-48.59M
-30.60%-12.23M
Operating gains losses
----
----
----
1,106.67%302K
--0
140.00%6K
--200K
740.00%96K
94.97%-30K
--0
Depreciation and amortization
0.00%332K
-1.20%328K
-7.54%331K
0.30%1.35M
-6.27%329K
-2.92%332K
3.75%332K
7.19%358K
96.64%1.35M
6.69%351K
Other non cash items
23.90%394K
9.63%387K
17.09%370K
13.65%1.36M
20.52%370K
6.00%318K
19.26%353K
8.59%316K
1,994.74%1.19M
501.96%307K
Change In working capital
-38.41%603K
104.96%85K
55.32%-1.43M
-529.56%-4.33M
-161.07%-400K
-78.46%979K
51.35%-1.72M
-378.86%-3.19M
761.54%1.01M
604.30%655K
-Change in prepaid assets
5.07%497K
-44.71%371K
54.68%-716K
82.99%-99K
-26.42%337K
-75.05%473K
172.23%671K
21.28%-1.58M
-170.29%-582K
-29.75%458K
-Change in payables and accrued expense
-93.63%30K
84.36%-354K
26.45%306K
-215.57%-2.33M
-324.46%-781K
-78.92%471K
15.47%-2.26M
-90.85%242K
241.44%2.02M
81.93%-184K
-Change in other current assets
245.24%61K
60.76%127K
800.00%56K
340.00%22K
73.08%-7K
2.33%-42K
178.22%79K
-104.57%-8K
101.53%5K
69.41%-26K
-Change in other current liabilities
-55.48%-468K
-17.66%-393K
-36.53%-370K
-11.48%-1.27M
-24.91%-366K
-5.24%-301K
-21.01%-334K
5.24%-271K
-656.59%-1.14M
-172.17%-293K
-Change in other working capital
27.78%483K
153.03%334K
55.42%-703K
-191.68%-650K
-40.43%417K
-49.19%378K
-71.18%132K
-32.19%-1.58M
-15.29%709K
407.25%700K
Cash from discontinued investing activities
Operating cash flow
-17.36%-5.47M
38.79%-5.79M
35.11%-7.62M
17.94%-32.02M
35.63%-6.16M
31.49%-4.66M
20.47%-9.46M
-9.17%-11.74M
-28.97%-39.03M
-21.68%-9.57M
Investing cash flow
Cash flow from continuing investing activities
55.37%12.91M
-64.63%6.91M
149.57%5.77M
-23.10%38.41M
-48.50%8.26M
-2.41%8.31M
47.97%19.53M
-81.04%2.31M
134.90%49.95M
185.87%16.04M
Net PPE purchase and sale
--0
-185.16%-109K
73.94%-37K
95.42%-14K
--0
--0
346.15%128K
-647.37%-142K
82.08%-306K
--0
Net investment purchase and sale
55.37%12.91M
-63.83%7.02M
136.63%5.81M
-23.54%38.43M
-48.50%8.26M
-5.03%8.31M
46.42%19.4M
-79.91%2.45M
135.54%50.26M
160.99%16.04M
Cash from discontinued investing activities
Investing cash flow
55.37%12.91M
-64.63%6.91M
149.57%5.77M
-23.10%38.41M
-48.50%8.26M
-2.41%8.31M
47.97%19.53M
-81.04%2.31M
134.90%49.95M
185.87%16.04M
Financing cash flow
Cash flow from continuing financing activities
91.95%-204K
97.73%-180K
20.23%-209K
-3,793.03%-11.17M
-247.58%-431K
-1,454.60%-2.53M
-6,577.31%-7.95M
-320.17%-262K
-100.18%-287K
-5.08%-124K
Net issuance payments of debt
-7.37%-204K
-6.35%-201K
-6.99%-199K
-20.99%-761K
-10.73%-196K
-16.56%-190K
-21.15%-189K
-39.85%-186K
-146.67%-629K
22.03%-177K
Net common stock issuance
--0
----
----
---10.38M
---252K
---2.34M
----
----
--0
--0
Proceeds from stock option exercised by employees
--0
----
----
-85.96%48K
-67.92%17K
--0
----
----
213.76%342K
-50.93%53K
Net other financing activities
--0
--0
86.84%-10K
---76K
--0
--0
--0
---76K
----
----
Cash from discontinued financing activities
Financing cash flow
91.95%-204K
97.73%-180K
20.23%-209K
-3,793.03%-11.17M
-247.58%-431K
-1,454.60%-2.53M
-6,577.31%-7.95M
-320.17%-262K
-100.18%-287K
-5.08%-124K
Net cash flow
Beginning cash position
16.28%11.89M
35.11%10.96M
-26.88%13.01M
148.57%17.8M
-0.93%11.34M
3.30%10.23M
-7.02%8.11M
148.57%17.8M
-56.86%7.16M
20.11%11.45M
Current changes in cash
548.16%7.24M
-55.83%935K
78.78%-2.06M
-144.98%-4.78M
-73.71%1.67M
-27.98%1.12M
79.71%2.12M
-720.10%-9.69M
212.71%10.64M
367.27%6.35M
End cash Position
68.66%19.13M
16.28%11.89M
35.11%10.96M
-26.88%13.01M
-26.88%13.01M
-0.93%11.34M
3.30%10.23M
-7.02%8.11M
148.57%17.8M
148.57%17.8M
Free cash flow
-17.36%-5.47M
37.83%-5.9M
35.62%-7.65M
18.16%-32.2M
35.63%-6.16M
33.91%-4.66M
20.58%-9.49M
-10.38%-11.89M
-21.87%-39.35M
-13.94%-9.57M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -17.36%-5.47M38.79%-5.79M35.11%-7.62M17.94%-32.02M35.63%-6.16M31.49%-4.66M20.47%-9.46M-9.17%-11.74M-28.97%-39.03M-21.68%-9.57M
Net income from continuing operations -1.81%-7.25M23.91%-7.14M21.47%-7.99M29.82%-34.1M39.39%-7.41M46.90%-7.12M10.91%-9.39M17.96%-10.18M-32.05%-48.59M-30.60%-12.23M
Operating gains losses ------------1,106.67%302K--0140.00%6K--200K740.00%96K94.97%-30K--0
Depreciation and amortization 0.00%332K-1.20%328K-7.54%331K0.30%1.35M-6.27%329K-2.92%332K3.75%332K7.19%358K96.64%1.35M6.69%351K
Other non cash items 23.90%394K9.63%387K17.09%370K13.65%1.36M20.52%370K6.00%318K19.26%353K8.59%316K1,994.74%1.19M501.96%307K
Change In working capital -38.41%603K104.96%85K55.32%-1.43M-529.56%-4.33M-161.07%-400K-78.46%979K51.35%-1.72M-378.86%-3.19M761.54%1.01M604.30%655K
-Change in prepaid assets 5.07%497K-44.71%371K54.68%-716K82.99%-99K-26.42%337K-75.05%473K172.23%671K21.28%-1.58M-170.29%-582K-29.75%458K
-Change in payables and accrued expense -93.63%30K84.36%-354K26.45%306K-215.57%-2.33M-324.46%-781K-78.92%471K15.47%-2.26M-90.85%242K241.44%2.02M81.93%-184K
-Change in other current assets 245.24%61K60.76%127K800.00%56K340.00%22K73.08%-7K2.33%-42K178.22%79K-104.57%-8K101.53%5K69.41%-26K
-Change in other current liabilities -55.48%-468K-17.66%-393K-36.53%-370K-11.48%-1.27M-24.91%-366K-5.24%-301K-21.01%-334K5.24%-271K-656.59%-1.14M-172.17%-293K
-Change in other working capital 27.78%483K153.03%334K55.42%-703K-191.68%-650K-40.43%417K-49.19%378K-71.18%132K-32.19%-1.58M-15.29%709K407.25%700K
Cash from discontinued investing activities
Operating cash flow -17.36%-5.47M38.79%-5.79M35.11%-7.62M17.94%-32.02M35.63%-6.16M31.49%-4.66M20.47%-9.46M-9.17%-11.74M-28.97%-39.03M-21.68%-9.57M
Investing cash flow
Cash flow from continuing investing activities 55.37%12.91M-64.63%6.91M149.57%5.77M-23.10%38.41M-48.50%8.26M-2.41%8.31M47.97%19.53M-81.04%2.31M134.90%49.95M185.87%16.04M
Net PPE purchase and sale --0-185.16%-109K73.94%-37K95.42%-14K--0--0346.15%128K-647.37%-142K82.08%-306K--0
Net investment purchase and sale 55.37%12.91M-63.83%7.02M136.63%5.81M-23.54%38.43M-48.50%8.26M-5.03%8.31M46.42%19.4M-79.91%2.45M135.54%50.26M160.99%16.04M
Cash from discontinued investing activities
Investing cash flow 55.37%12.91M-64.63%6.91M149.57%5.77M-23.10%38.41M-48.50%8.26M-2.41%8.31M47.97%19.53M-81.04%2.31M134.90%49.95M185.87%16.04M
Financing cash flow
Cash flow from continuing financing activities 91.95%-204K97.73%-180K20.23%-209K-3,793.03%-11.17M-247.58%-431K-1,454.60%-2.53M-6,577.31%-7.95M-320.17%-262K-100.18%-287K-5.08%-124K
Net issuance payments of debt -7.37%-204K-6.35%-201K-6.99%-199K-20.99%-761K-10.73%-196K-16.56%-190K-21.15%-189K-39.85%-186K-146.67%-629K22.03%-177K
Net common stock issuance --0-----------10.38M---252K---2.34M----------0--0
Proceeds from stock option exercised by employees --0---------85.96%48K-67.92%17K--0--------213.76%342K-50.93%53K
Net other financing activities --0--086.84%-10K---76K--0--0--0---76K--------
Cash from discontinued financing activities
Financing cash flow 91.95%-204K97.73%-180K20.23%-209K-3,793.03%-11.17M-247.58%-431K-1,454.60%-2.53M-6,577.31%-7.95M-320.17%-262K-100.18%-287K-5.08%-124K
Net cash flow
Beginning cash position 16.28%11.89M35.11%10.96M-26.88%13.01M148.57%17.8M-0.93%11.34M3.30%10.23M-7.02%8.11M148.57%17.8M-56.86%7.16M20.11%11.45M
Current changes in cash 548.16%7.24M-55.83%935K78.78%-2.06M-144.98%-4.78M-73.71%1.67M-27.98%1.12M79.71%2.12M-720.10%-9.69M212.71%10.64M367.27%6.35M
End cash Position 68.66%19.13M16.28%11.89M35.11%10.96M-26.88%13.01M-26.88%13.01M-0.93%11.34M3.30%10.23M-7.02%8.11M148.57%17.8M148.57%17.8M
Free cash flow -17.36%-5.47M37.83%-5.9M35.62%-7.65M18.16%-32.2M35.63%-6.16M33.91%-4.66M20.58%-9.49M-10.38%-11.89M-21.87%-39.35M-13.94%-9.57M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data